期刊文献+

六味地黄方对高脂血症大鼠血管内皮细胞的保护作用 被引量:13

Protection effect of Liweidihuang Formula (LWDHF,六味地黄方) on endothelial cell in experimental hyperlipidemic rats
下载PDF
导出
摘要 目的:研究六味地黄方对高脂血症大鼠血管内皮细胞的保护作用。方法:高脂饮食建立高脂血症大鼠模型,观察大鼠血脂、血清超氧化物歧化酶(SOD)、丙二醛(MDA)、一氧化氮(NO)、一氧化氮合酶(NOS)及外周血循环内皮细胞(CEC)的变化。结果:高脂模型组血清TC、TG、LDLC、MDA、CEC均明显升高,HDLC、SOD、NO、NOS显著下降;六味地黄方可降低模型大鼠血清TC、TG、LDLC、MDA、CEC,升高HDLC、SOD、NO、NOS。结论:六味地黄方具有调节脂质代谢、抗脂质过氧化反应、升高NO水平,保护血管内皮细胞的作用。 Objective: To determine the protective effects of Liuweidihuang Formula (LWDHF) on endothelial cells in the experimental hyperlipidemic rats. Methods: The hyperlipidemic model in rats was set up by feeding high cholesterol diet. Serum lipid, superoxide dismutase (SOD) , malondialdehyde (MDA) , nitric oxide (NO) , nitricoxide synthase (NOS) and circulating endothelial cells ( CEC ) in peripheral blood were measured. Result: Serum TC, TG, LDL-C, MDA concentration and CEC were significantly decreased but serum HDL-C, SOD, NO, NOS levels and CEC were evidently increased in LWDHF treated groups as compared with those of hyperlipidemic group( P 〈0.05 or P 〈 0.01 ). Conclusion: The results indicate that LWDHF can modulate lipid metabolism, inhibit lipid peroxidation ,increase NO, thus might protect vascular endothelial cells.
出处 《中药药理与临床》 CAS CSCD 北大核心 2006年第1期5-7,共3页 Pharmacology and Clinics of Chinese Materia Medica
基金 江苏省教育厅自然科学基金资助项目(02KJB360005) 江苏省中医药局资助项目(H004) 江苏省科技厅基金项目(BK2001125) 国家自然科学基金项目(30271577)
关键词 六味地黄方 高脂血症 血管内皮 循环内皮细胞 SOD MDA Liuweidihuang Formula ( 六味地黄方) hyperlipidemic VEC CEC SOD MDA NO NOS
  • 相关文献

参考文献8

二级参考文献15

  • 1吴旭,林水金,杨映波,冯素珍.蜕皮甾酮对人脐静脉内皮细胞增殖的影响[J].中国药理学通报,1997,13(2):176-179. 被引量:33
  • 2宋勇 毛宝龄 王建春.一次性获得脐动、静脉内皮细胞的实验技术[J].细胞生物学杂志,2000,(2):128-128.
  • 3[1]Dzau VJ, Gibbons Gh, Mann M,et al. Future horizons in cardiovascular molecular therapies. Am J Cardiol,1997;80(9A):33I~39I
  • 4[2]Umeda Y, Kako Y, Mizutani K, et al. Inhibitory action of gemfibrozil on cholesterol absorption in rat intestine. J Lipid Res,2001 ;42(8): 1214~1219
  • 5[3]Gibbons GH. Endothelial function as a determinant of vascular function and structure: A new therapeutic target. Am J Cardiol,1997;79(5A):3~8
  • 6[4]Hirata K, Miki N, Kuroda y, et al. Low concentration of oxidized low-density lipoprotein and lysophosphatidylcholine upregulate constitutive nitric oxide synthase mRNA expression in bovine aortic endothelial cells. Circ Res,1995; 76(6):958~962
  • 7[5]Yang BC, Phillips MI, Mohuczy D, et al. Increased angiotensin Ⅱ type1 receptor expression in hypercholesterolemic atherosclerosis in rabbits.Arterioscler Thromb Vasc Biol,1998;18(9):1433~1439
  • 8[6]Elsasser A, Schlepper M, Klovekom WP, et al. Hibernation myocardium-an incomplete adaptation to ischemia. Circulation,1997;96(9):2920~2931
  • 9[7]Bouloumie A, Schini-Kerth VB, Busse R. Vascular endothelial growthfactor up-regulates nitric oxide synthase expression in endothelial cells.Cardiovasc Res,1999;41 (3):773~780
  • 10于树臣,刘吉平.六味地黄丸的临床应用[J].吉林中医药,1997,17(3):43-44. 被引量:5

共引文献55

同被引文献198

引证文献13

二级引证文献92

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部